Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
IRLAIRulya Therapeutics Inc.
| Figure | IRLAIRulya Therapeutics Inc.FY2025 · Dec |
|---|---|
| Revenue | — |
| Revenue, yoy | — |
| Net income | $83.98M |
| Net income, yoy | −47.8% |
| Net margin | — |
| Free cash flow | $41.78M |
| FCF margin | — |
| EPS, diluted | $1.68 |
Add another company.
Annual · USD
No annual figures on file for this.
From SEC EDGARSame fiscal periods, as filed